Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

A Universal Droplet Digital PCR Approach for Monitoring of Graft Health After Transplantation Using a Preselected SNP Set.

Beck J, Oellerich M, Schütz E.

Methods Mol Biol. 2018;1768:335-348. doi: 10.1007/978-1-4939-7778-9_19.

PMID:
29717452
2.

Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer.

Schirmer MA, Beck J, Leu M, Oellerich M, Rave-Fränk M, Walson PD, Schütz E, Canis M.

Clin Chem. 2018 Jun;64(6):959-970. doi: 10.1373/clinchem.2017.285668. Epub 2018 Apr 16.

PMID:
29661793
3.

Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.

Nörthen A, Asendorf T, Walson PD, Oellerich M.

Clin Biochem. 2018 Feb;52:20-25. doi: 10.1016/j.clinbiochem.2017.10.011. Epub 2017 Oct 17.

PMID:
29054441
4.

Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.

Schütz E, Fischer A, Beck J, Harden M, Koch M, Wuensch T, Stockmann M, Nashan B, Kollmar O, Matthaei J, Kanzow P, Walson PD, Brockmöller J, Oellerich M.

PLoS Med. 2017 Apr 25;14(4):e1002286. doi: 10.1371/journal.pmed.1002286. eCollection 2017 Apr.

5.

Using circulating cell-free DNA to monitor personalized cancer therapy.

Oellerich M, Schütz E, Beck J, Kanzow P, Plowman PN, Weiss GJ, Walson PD.

Crit Rev Clin Lab Sci. 2017 May;54(3):205-218. doi: 10.1080/10408363.2017.1299683. Epub 2017 Apr 10. Review.

PMID:
28393575
6.

Therapeutic drug monitoring - Key to personalized pharmacotherapy.

Oellerich M, Kanzow P, Walson PD.

Clin Biochem. 2017 May;50(7-8):375-379. doi: 10.1016/j.clinbiochem.2017.01.007. Epub 2017 Jan 14. Review. No abstract available.

PMID:
28095311
7.

Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial.

Billing H, Höcker B, Fichtner A, van Damme-Lombaerts R, Friman S, Jaray J, Vondrak K, Sarvary E, Dello Strologo L, Oellerich M, von Ahsen N, Tönshoff B.

Ther Drug Monit. 2017 Feb;39(1):21-28. doi: 10.1097/FTD.0000000000000361.

PMID:
28030534
8.

Leveraging the real value of laboratory medicine with the value proposition.

Price CP, John AS, Christenson R, Scharnhorst V, Oellerich M, Jones P, Morris HA.

Clin Chim Acta. 2016 Nov 1;462:183-186. doi: 10.1016/j.cca.2016.09.006. Epub 2016 Sep 17.

PMID:
27649855
9.

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee.

Seger C, Shipkova M, Christians U, Billaud EM, Wang P, Holt DW, Brunet M, Kunicki PK, Pawiński T, Langman LJ, Marquet P, Oellerich M, Wieland E, Wallemacq P.

Ther Drug Monit. 2016 Apr;38(2):170-89. doi: 10.1097/FTD.0000000000000269. Review.

PMID:
26982493
10.

Therapeutic Drug Monitoring of Everolimus: A Consensus Report.

Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, Brunet M, Budde K, Barten MJ, De Simone P, Wieland E, López OM, Masuda S, Seger C, Picard N, Oellerich M, Langman LJ, Wallemacq P, Morris RG, Thompson C, Marquet P.

Ther Drug Monit. 2016 Apr;38(2):143-69. doi: 10.1097/FTD.0000000000000260.

PMID:
26982492
11.

Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.

Brunet M, Shipkova M, van Gelder T, Wieland E, Sommerer C, Budde K, Haufroid V, Christians U, López-Hoyos M, Barten MJ, Bergan S, Picard N, Millán López O, Marquet P, Hesselink DA, Noceti O, Pawinski T, Wallemacq P, Oellerich M.

Ther Drug Monit. 2016 Apr;38 Suppl 1:S1-20. doi: 10.1097/FTD.0000000000000287. Review.

PMID:
26977997
12.

Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.

Graff J, Scheuermann EH, Brandhorst G, Oellerich M, Gossmann J.

Ther Drug Monit. 2016 Jun;38(3):388-92. doi: 10.1097/FTD.0000000000000281.

PMID:
26829599
13.

FOXO1 couples metabolic activity and growth state in the vascular endothelium.

Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, Zimmermann B, Aspalter IM, Franco CA, Boettger T, Braun T, Fruttiger M, Rajewsky K, Keller C, Brüning JC, Gerhardt H, Carmeliet P, Potente M.

Nature. 2016 Jan 14;529(7585):216-20. doi: 10.1038/nature16498. Epub 2016 Jan 6.

14.

Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation.

Beck J, Oellerich M, Schulz U, Schauerte V, Reinhard L, Fuchs U, Knabbe C, Zittermann A, Olbricht C, Gummert JF, Shipkova M, Birschmann I, Wieland E, Schütz E.

Transplant Proc. 2015 Oct;47(8):2400-3. doi: 10.1016/j.transproceed.2015.08.035.

PMID:
26518940
15.

Mycophenolic acid reverses TGF beta-induced cell motility, collagen matrix contraction and cell morphology in vitro.

Petrova DT, Brandhorst G, Koch C, Schultze FC, Eberle C, Walson PD, Oellerich M.

Cell Biochem Funct. 2015 Oct;33(7):503-8. doi: 10.1002/cbf.3149. Epub 2015 Oct 8.

PMID:
26449633
16.

Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury.

Oellerich M, Walson PD, Beck J, Schmitz J, Kollmar O, Schütz E.

Ther Drug Monit. 2016 Apr;38 Suppl 1:S75-9. doi: 10.1097/FTD.0000000000000239. Review.

PMID:
26418703
17.

Thiopurines induce oxidative stress in T-lymphocytes: a proteomic approach.

Misdaq M, Ziegler S, von Ahsen N, Oellerich M, Asif AR.

Mediators Inflamm. 2015;2015:434825. doi: 10.1155/2015/434825. Epub 2015 Mar 22.

18.

Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.

Brandhorst G, Petrova DT, Weigand S, Eberle C, von Ahsen N, Schmitz J, Schultze FC, Raddatz D, Karaus M, Oellerich M, Walson PD.

World J Gastroenterol. 2015 Mar 21;21(11):3325-9. doi: 10.3748/wjg.v21.i11.3325.

19.

Offie Soldin, PhD, MBA.

Oellerich M, Koren G.

Ther Drug Monit. 2015 Feb;37(1):1. No abstract available.

PMID:
25734206
20.

FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation.

Oellerich T, Mohr S, Corso J, Beck J, Döbele C, Braun H, Cremer A, Münch S, Wicht J, Oellerich MF, Bug G, Bohnenberger H, Perske C, Schütz E, Urlaub H, Serve H.

Blood. 2015 Mar 19;125(12):1936-47. doi: 10.1182/blood-2014-06-585216. Epub 2015 Jan 20.

21.

Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice.

Petrova DT, Schultze FC, Brandhorst G, Luchs KD, Lenz C, Urlaub H, Rubel D, Gross O, Walson PD, Oellerich M.

Proteome Sci. 2014 Dec 10;12(1):56. doi: 10.1186/s12953-014-0056-z. eCollection 2014.

22.

Crosstalk between Edc4 and mammalian target of rapamycin complex 1 (mTORC1) signaling in mRNA decapping.

Rahman H, Qasim M, Oellerich M, Asif AR.

Int J Mol Sci. 2014 Dec 12;15(12):23179-95. doi: 10.3390/ijms151223179.

23.

Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver.

Kanzow P, Kollmar O, Schütz E, Oellerich M, Schmitz J, Beck J, Walson PD, Slotta JE.

Transplantation. 2014 Sep 15;98(5):e43-5. doi: 10.1097/TP.0000000000000303. No abstract available.

PMID:
25171533
24.

The changing face of laboratory medicine: a more service and less academically oriented profession?

Scott MG, Rifai N, Smith B, Oellerich M, Panteghini M, Apple F, Sikaris K, Young I.

Clin Chem. 2015 Feb;61(2):322-9. doi: 10.1373/clinchem.2014.230300. Epub 2014 Aug 26. No abstract available.

25.

Allergic aspergillosis and the antigens of Aspergillus fumigatus.

Singh B, Singh S, Asif AR, Oellerich M, Sharma GL.

Curr Protein Pept Sci. 2014;15(5):403-23. Review.

26.

Identification of the novel interacting partners of the mammalian target of rapamycin complex 1 in human CCRF-CEM and HEK293 cells.

Rahman H, Qasim M, Oellerich M, Asif AR.

Int J Mol Sci. 2014 Mar 18;15(3):4823-36. doi: 10.3390/ijms15034823.

27.

Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.

Shipkova M, Petrova DT, Rosler AE, Orth M, Engelmayer J, Wieland E, Brandhorst G, Oellerich M.

Ther Drug Monit. 2014 Aug;36(4):433-41. doi: 10.1097/FTD.0000000000000043.

PMID:
24646729
28.

Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.

Qasim M, Rahman H, Ahmed R, Oellerich M, Asif AR.

Exp Cell Res. 2014 Apr 1;322(2):277-89. doi: 10.1016/j.yexcr.2014.01.021. Epub 2014 Feb 7.

PMID:
24509232
29.

Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.

Oellerich M, Schütz E, Kanzow P, Schmitz J, Beck J, Kollmar O, Streit F, Walson PD.

Ther Drug Monit. 2014 Apr;36(2):136-40. doi: 10.1097/FTD.0000000000000044.

PMID:
24452066
30.

Differential expression of proteins in brain regions of Alzheimer's disease patients.

Zahid S, Oellerich M, Asif AR, Ahmed N.

Neurochem Res. 2014 Jan;39(1):208-15. doi: 10.1007/s11064-013-1210-1. Epub 2013 Dec 4.

PMID:
24306222
31.

FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue.

Schultze FC, Andag R, Alwahsh SM, Toncheva D, Maslyankov S, Yaramov N, von Ahsen N, Brandhorst G, Walson PD, Oellerich M, Petrova DT.

Clin Biochem. 2014 Feb;47(3):201-5. doi: 10.1016/j.clinbiochem.2013.11.013. Epub 2013 Nov 26.

PMID:
24291052
32.

Differential S-nitrosylation of proteins in Alzheimer's disease.

Zahid S, Khan R, Oellerich M, Ahmed N, Asif AR.

Neuroscience. 2014 Jan 3;256:126-36. doi: 10.1016/j.neuroscience.2013.10.026. Epub 2013 Oct 22.

PMID:
24157928
33.

Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury.

Beck J, Bierau S, Balzer S, Andag R, Kanzow P, Schmitz J, Gaedcke J, Moerer O, Slotta JE, Walson P, Kollmar O, Oellerich M, Schütz E.

Clin Chem. 2013 Dec;59(12):1732-41. doi: 10.1373/clinchem.2013.210328. Epub 2013 Sep 23.

34.

Can the Roche hemolysis index be used for automated determination of cell-free hemoglobin? A comparison to photometric assays.

Petrova DT, Cocisiu GA, Eberle C, Rhode KH, Brandhorst G, Walson PD, Oellerich M.

Clin Biochem. 2013 Sep;46(13-14):1298-301. doi: 10.1016/j.clinbiochem.2013.06.018. Epub 2013 Jul 2.

PMID:
23830841
35.

Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.

Wagner NM, Brandhorst G, Czepluch F, Lankeit M, Eberle C, Herzberg S, Faustin V, Riggert J, Oellerich M, Hasenfuss G, Konstantinides S, Schäfer K.

Obesity (Silver Spring). 2013 Mar;21(3):461-8. doi: 10.1002/oby.20087.

36.

β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis.

Oellerich T, Oellerich MF, Engelke M, Münch S, Mohr S, Nimz M, Hsiao HH, Corso J, Zhang J, Bohnenberger H, Berg T, Rieger MA, Wienands J, Bug G, Brandts C, Urlaub H, Serve H.

Blood. 2013 May 9;121(19):3889-99, S1-66. doi: 10.1182/blood-2012-09-457887. Epub 2013 Mar 18.

37.

CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.

Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD.

Clin Chim Acta. 2013 Jun 5;421:31-3. doi: 10.1016/j.cca.2013.02.016. Epub 2013 Feb 26.

PMID:
23485644
38.

Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach.

Biswas S, Sharma S, Saroha A, Bhakuni DS, Malhotra R, Zahur M, Oellerich M, Das HR, Asif AR.

PLoS One. 2013;8(2):e56246. doi: 10.1371/journal.pone.0056246. Epub 2013 Feb 13.

39.

Pharmacokinetics of meropenem in critically ill patients with severe infections.

Binder L, Schwörer H, Hoppe S, Streit F, Neumann S, Beckmann A, Wachter R, Oellerich M, Walson PD.

Ther Drug Monit. 2013 Feb;35(1):63-70. doi: 10.1097/FTD.0b013e31827d496c.

PMID:
23318279
40.

Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.

Misdaq M, Andag R, Oellerich M, Asif AR, von Ahsen N.

Ther Drug Monit. 2012 Oct;34(5):584-92. doi: 10.1097/FTD.0b013e31826ec4b4.

PMID:
22972540
41.

Biomarkers in transplantation medicine: guide to the next level in immunosuppressive therapy.

Wieland E, Shipkova M, Oellerich M.

Clin Chim Acta. 2012 Sep 8;413(17-18):1309. doi: 10.1016/j.cca.2012.05.011. Epub 2012 May 19. No abstract available.

PMID:
22640572
42.

FOXOs and sirtuins in vascular growth, maintenance, and aging.

Oellerich MF, Potente M.

Circ Res. 2012 Apr 27;110(9):1238-51. doi: 10.1161/CIRCRESAHA.111.246488. Review.

PMID:
22539757
43.

Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.

Neumann S, Frenz M, Streit F, Oellerich M.

Can J Vet Res. 2011 Oct;75(4):317-20.

44.

Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients.

Zahid S, Oellerich M, Asif AR, Ahmed N.

J Neurochem. 2012 Jun;121(6):954-63. doi: 10.1111/j.1471-4159.2012.07737.x. Epub 2012 Apr 24.

45.

Confronting the challenge: individualized immune monitoring after organ transplantation using the cellular immune function assay.

Israeli M, Klein T, Brandhorst G, Oellerich M.

Clin Chim Acta. 2012 Sep 8;413(17-18):1374-8. doi: 10.1016/j.cca.2012.01.033. Epub 2012 Feb 3. Review.

PMID:
22333671
46.

Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.

Rother A, Glander P, Vitt E, Czock D, von Ahsen N, Armstrong VW, Oellerich M, Budde K, Feneberg R, Tönshoff B, Weber LT.

Eur J Clin Pharmacol. 2012 Jun;68(6):913-22. doi: 10.1007/s00228-011-1203-4. Epub 2012 Jan 25.

PMID:
22274404
47.

Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring?

Brandhorst G, Oellerich M, Maine G, Taylor P, Veen G, Wallemacq P.

Clin Chem. 2012 May;58(5):821-5. doi: 10.1373/clinchem.2011.167189. Epub 2012 Jan 17. No abstract available.

48.

Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.

Schulz-Juergensen S, Burdelski MM, Oellerich M, Brandhorst G.

Ther Drug Monit. 2012 Feb;34(1):4-10. doi: 10.1097/FTD.0b013e31823c5668.

PMID:
22210096
49.

Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Nasim FU, Ejaz S, Ashraf M, Asif AR, Oellerich M, Ahmad G, Malik GA, Attiq-Ur-Rehman.

Biomark Cancer. 2012 Dec 10;4:19-34. doi: 10.4137/BIC.S10502. eCollection 2012.

50.

Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome.

Rahman H, Qasim M, Schultze FC, Oellerich M, R Asif A.

Proteome Sci. 2011 Nov 15;9(1):71. doi: 10.1186/1477-5956-9-71.

Supplemental Content

Loading ...
Support Center